2023 Agenda

*Schedule is tentative and is subject to change.

Print Friendly, PDF & Email

Cellular Therapies and Novel Blood Products in Trauma and Critical Care – The Future of Transfusion Medicine

Monday, May 8

2:00 pm-7:00 pm
Registration Desk Open – Alhambra Foyer
Badge and Materials Pick Up

4:00 pm-5:30 pm
Moderator/Speaker/Panel Briefing with A-V in Gen Session room – Alhambra Ballroom

6:30 pm-8:00 pm
Welcome Reception – Oasis Pool Bar
(Hors-d’oeurves, dinner on your own)

Tuesday, May 9 | Blood Products in Trauma and Critical Care

7:00 am-8:00 am
Breakfast – Alhambra Terrace

7:00 am-5:30 pm
Registration Desk Open – Alhambra Foyer
Badge and Materials Pick Up

8:00 am-6:00 pm
General Session – Alhambra Ballroom

8:00 am-8:10 am
Welcome & Introductions

  • Shibani Pati MD, PhD
    CTTACC Conference Chair
    Professor of Laboratory Medicine and Surgery, UCSF
    Scientific Director of Cellular Therapies

Session 1 | Whole Blood-The First Cell Therapy

This session will focus upon the pathophysiology of bleeding and coagulopathy in trauma. Focus areas will be on the utilization of whole blood in bleeding trauma patients and the optimization of resuscitation practice.

Moderator(s)

  • Martin Schreiber MD, FCCM, FACS
    CTTACC Conference Co-Chair
    COL USAR
    Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
    Oregon Health & Science University (OHSU)

  • John Holcomb MD, FACS
    COL, USA (Ret)
    Professor of Surgery, Department of Surgery
    University of Alabama at Birmingham

8:10 am-8:30 am
The Pathophysiology of Trauma Induced Coagulopathy : Rationale for Whole Blood Resuscitation

  • Ernest “Gene” Moore MD, FACS
    Distinguished Professor of Surgery
    Vice Chairman for Research
    University of Colorado Denver, Anschutz Medical Campus

8:30 am-8:50 am
Adjuncts to Whole Blood (Tranexamic Acid-TXA)

  • Jason Sperry MD, MPH, FACS
    Section Chief, Trauma Surgery
    Professor of Surgery and Critical Care
    Director of Acute Care Surgery Fellowship
    University of Pittsburgh

8:50 am-9:10 am
Fresh Warm Whole Blood vs Liquid Cold Stored Whole Blood/Comparisons and Differences

  • Andrew (Andre) Cap MD, PhD
    COL MC USA
    Director of Research, US Army Institute of Surgical Research
    Hematology-Oncology Consultant to the US Army Surgeon General
    NATO Blood Panel Co-Chair
    Professor of Medicine, Uniformed Services University
    Hematology/Oncology/BMT Staff, San Antonio Military Medical Center

9:10 am-9:30 am
Can We Make DCR ‘Perfect’ Every Time? Machine Learning and Real-Time Performance Improvement to Optimize Resuscitation

  • Jeremy Cannon MD, SM, FACS
    Col, USAFR
    Professor of Surgery

    Trauma Medical Director and Section Chief of Trauma
    Perelman School of Medicine, University of Pennsylvania

9:30 am-9:40 am
Question & Answer Panel | Session 1

9:40 am-10:00 am
Coffee Break – Alhambra Ballroom & Terrace
Visit Exhibits/Posters

Session 2 | Blood Shortages and Adjunctive Therapies to Reduce Blood Utilization

This session will focus on the areas of blood shortages and how to manage and optimize blood utilization. The discussion panel will debate bloodless surgery and the ethics of rationing blood products in patients.

Moderator(s)

  • Beth Shaz MD, MBA
    Professor and Deputy Director of Marcus Center for Cellular Cures
    Duke University

  • Joseph Rappold MD, FACS
    CAPT MC USN (Ret)
    Professor of Surgery
    Maine Medical Center / Tufts University

10:00 am-10:15 am
Effect of Blood Shortages on Trauma Patient Management-Blood Equity

  • Martin Schreiber MD, FCCM, FACS
    CTTACC Conference Co-Chair
    COL USAR
    Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
    Oregon Health & Science University (OHSU)

10:15 am-10:25 am
Walking Blood Banks in Times of Blood Shortages

  • John Holcomb MD, FACS
    COL, USA (Ret)
    Professor of Surgery, Department of Surgery
    University of Alabama at Birmingham

10:25 am-11:10 am
Panel Debate – Bloodless Surgery and the Ethics of Limiting Blood in Patients

Moderator(s)

  • Beth Shaz MD, MBA
    Professor and Deputy Director of Marcus Center for Cellular Cures
    Duke University

     

  • Joseph Rappold MD, FACS
    CAPT MC USN (Ret)
    Professor of Surgery
    Maine Medical Center / Tufts University

Panelist(s)

  • Andrew (Andre) Cap MD, PhD
    COL MC USA
    Director of Research, US Army Institute of Surgical Research
    Hematology-Oncology Consultant to the US Army Surgeon General
    NATO Blood Panel Co-Chair
    Professor of Medicine, Uniformed Services University
    Hematology/Oncology/BMT Staff, San Antonio Military Medical Center

     

  • Pampee Young MD, PhD
    Chief Medical Officer, Biomedical Services, American Red Cross, Nashville, TN
    Adjunct Professor, Vanderbilt University, Cell and Developmental Biology
    Adjunct Professor, Pathology, Microbiology and Immunology

     

  • Martin Schreiber MD, FACS
    CTTACC Conference Co-Chair
    COL USAR
    Professor of Surgery & Chief of Trauma, Critical Care & Acute Care Surgery
    Oregon Health & Science University (OHSU)
  • Ernest “Gene” Moore MD, FACS
    Distinguished Professor of Surgery
    Vice Chairman for Research
    University of Colorado Denver, Anschutz Medical Campus

Special Interest Talk

11:10am-11:45am
A Scientific Journey with VEGFR2 from Bench to Bedside

  • Napoleone Ferrara, MD
    Distinguished Professor of Pathology
    Adjunct Professor of Ophthalmology and Pharmacology
    UCSD
11:45 am-12:45 pm
Lunch – Valencia Lawn

Session 3 | Cellular and Novel Therapeutics in Neurotrauma and Polytrauma

This session will focus on novel blood and cell therapies for traumatic brain injury (TBI) and spinal cord injury (SCI). Both clinical and pre-clinical studies will be presented.

Moderator(s)

  • Robert Mays PhD
    Executive Vice President, Regenerative Medicine
    Head of Neurosciences, Athersys, Inc
  • Hasan Alam MD, FACS
    Chair, Department of Surgery
    Loyal and Edith Davis Professor of Surgery
    Professor of Surgery (Trauma and Critical Care) and Cell and Developmental Biology
    Northwestern University
    Surgeon-in-Chief at Northwestern Memorial Hospital

12:45 pm-1:15 pm
Clinical Trial of Bone Marrow Mononuclear Cells for Severe TBI In Children
Clinical Trial of Autologous adipose Derived MSCs for Chronic TBI

  • Charles S. Cox Jr. MD, FACS
    The George and Cynthia Mitchell Distinguished Chair in Neurosciences
    Director, Children’s Program in Regenerative Medicine
    Professor, Department of Pediatric Surgery
    UTHealth Houston

1:15 pm-1:35 pm
Plasma for the Treatment of TBI: A Prospective Randomized Clinical Trial

  • Hasan Alam MD, FACS
    Chair, Department of Surgery
    Loyal and Edith Davis Professor of Surgery
    Professor of Surgery (Trauma and Critical Care) and Cell and Developmental Biology
    Northwestern University
    Surgeon-in-Chief at Northwestern Memorial Hospital

1:35 pm-1:55 pm
Clinical Trials of Stem Cells in Spinal Cord Injury

  • James Guest MD, PhD
    Clinical Professor, Department of Neurological Surgery
    Miller School of Medicine and Miami Project to Cure Paralysis
    University of Miami

1:55 pm-2:15 pm
Treating the Endotheliopathy of TBI with Novel Platelet Products 

  • Shibani Pati MD, PhD

    CTTACC Conference Chair

    Professor of Laboratory Medicine and Surgery, UCSF

    Scientific Director of Cellular Therapies

2:15 pm-2:35 pm
Question & Answer | Session 3

2:35 pm-2:50 pm
Coffee Break – Alhambra Ballroom & Terrace
Visit Exhibits/Posters

Session 4 | Platelet Biology and Novel Blood Products in Health and Disease

This session will discuss the pathophysiology of platelet and endothelial function in health and disease. Advances in novel platelet products and oxygen carriers will be presented.

Moderator(s)

  • Mike Fitzpatrick PhD
    COL USA (Ret)
    Chief Scientific Officer
    Cellphire Therapeutics, Inc.

  • Ernest “Gene” Moore MD, FACS
    Distinguished Professor of Surgery
    Vice Chairman for Research
    University of Colorado Denver, Anschutz Medical Campus

2:50 pm-3:10 pm
Platelet Biogenesis in The Lung and Spleen During Homeostasis and Injury

  • Mark R. Looney MD
    Professor of Medicine and Laboratory Medicine
    University California San Francisco

3:10 pm-3:30 pm
Synthetic Platelets for Use in Trauma and Hemorrhage

  • Anirban Sen Gupta PhD
    Professor
    Case Western University, Biomedical Engineering
    Cleveland

3:30 pm-3:50 pm
Microvascular Thrombosis – Innate Immune Signals that Drive Platelet Function

  • Matthew Neal MD, FACS
    Roberta G. Simmons Associate Professor of Surgery
    Co-Director, Trauma and Transfusion Medicine Research Center
    University of Pittsburgh

3:50 pm-4:10 pm
Intro to Whole Blood Substitute-DARPA

  • Jean-Paul Chretien MD, PhD
    CDR MC USN
    Program Manager
    Biological Technologies Office
    Defense Advanced Research Projects Agency (DARPA)

4:10 pm-4:30 pm
Synthetic Biology Meets Bio-Inspired Engineering: Path to a Whole Blood Analogue

  • Allan Doctor MD
    Professor of Pediatrics and Bioengineering
    Director, Center of Blood Oxygen Transport and Hemostasis
    CSO and Founding Partner, KaloCyte

4:30 pm-4:50 pm
Artificial Oxygen Carriers: Can We Use Them Now?

  • Jonathan Jahr MD, PhD, DABA, FASA
    Professor Emeritus of Anesthesiology and Perioperative Medicine
    David Geffen School of Medicine at UCLA
    Ronald Reagan UCLA Medical Center

4:50 pm-5:10 pm
A Journey in Understanding Post-Injury Platelet Behavior

  • Lucy Kornblith MD, FACS
    Assistant Professor of Surgery and Lab Medicine, UCSF
    Division of General Surgery
    Trauma and Surgical Critical Care
    Zuckerberg San Francisco General Hospital

5:10 pm-5:20 pm
Question & Answer Panel | Session 4

Special Interest Talk

5:20 pm-5:40 pm
Military Medical Research Making a Difference

  • Terry M. Rauch PhD, MPH, MBA
    Director of Medical Research and Development Health Readiness Policy & Oversight OASD(HA)
    Defense Health Headquarters

5:40 pm-5:50 pm
Moderator Q&A – John Holcomb MD, FACS

5:50 pm-7:00 pm
Reception – Kasbah Patio

7:00 pm-7:10 pm
Introduction of Keynote Speaker – Castillo Lucena

  • Kenneth Bertram MD, PhD
    Co-Chair CTTACC
    COL MC USA (Ret)
    Clinical Product Development Officer
    Wake Forest University

7:10 pm-7:40 pm
2023 Keynote
From Maricao to Scottsdale

  • HON Lester Martinez-Lopez MD
    Assistant Secretary of Defense for Health Affairs
     

7:40 pm-9:00 pm
Dinner – Cortijo Plaza

Wednesday, May 10 | Regenerative Medicine and Cell Therapies for Trauma and Critical Care Medicine. Addressing Threat X (BARDA)

7:00 am-8:00 am
Breakfast – Alhambra Terrace

7:00 am-5:30 pm
Registration Desk Open – Alhambra Foyer
Badge and Materials Pick Up

8:00 am-8:05 am
Welcome & Introductions

  • Shibani Pati MD, PhD
    CTTACC Conference Chair
    Professor of Laboratory Medicine and Surgery, UCSF
    Scientific Director of Cellular Therapies

Session 5 | Novel Cell Therapies and Blood Products for the Treatment of COVID-19

This session will discuss the pathophysiology of COVID-19 as well as pre-clinical and clinical data on novel therapies (cell and blood) that have been investigated to mitigate outcomes in COVID-19 patients.

Moderator(s)

  • Andrew (Andre) Cap MD, PhD
    COL MC USA
    Director of Research, US Army Institute of Surgical Research
    Hematology-Oncology Consultant to the US Army Surgeon General
    NATO Blood Panel Co-Chair
    Professor of Medicine, Uniformed Services University
    Hematology/Oncology/BMT Staff, San Antonio Military Medical Center

  • Raymond P. Goodrich, PhD
    Executive Director, Infectious Disease Research Center
    Office of the Vice President for Research
    Professor, Department of Microbiology, Immunology and Pathology
    Colorado State University

8:05 am-8:25 am
Immune Cell Activation in COVID-19

  • Clifford Lowell MD
    Distinguished Professor and Chair of Department of Laboratory Medicine
    University of California, San Francisco

8:25 am-8:45 am
Novel Extracorporeal Therapies for the Treatment of COVID-19… and Beyond

  • Kevin Chung MD
    COL MC USA (Ret)
    CMO SeaStar Medical

8:45 am-9:05 am
Impact of COVID-19 in the Deployed Setting-Lessons Learned

  • Jennifer Gurney MD, FACS
    Chief, Joint Trauma System
    COL MC USA
    US Army Institute of Surgical Research
    Fort Sam Houston

9:05 am-9:25 am
MSCs in ARDS due to COVID-19, a Randomised Clinical Trial- the REALIST Trial

  • Danny McAuley MD
    Professor and Consultant in Intensive Care Medicine
    Queen’s University of Belfast and Royal Victoria Hospital, Belfast

9:25 am-9:45 am
Allogeneic Off-the-Shelf CAR NK Cell Therapy for Treating COVID-19 and Cancer

  • Jianhua Yu PhD
    Professor in the Department of Hematology & Hematopoietic Cell Transplantation
    City of Hope

9:45 am-10:05 am
Bone Marrow MSCs in Acute COVID-19 Data from a Multi-Center, Randomized Placebo Controlled Clinical Trial (STAT)

  • Michael Matthay MD
    Professor of Pulmonary Critical Care Medicine
    Research Lab Director, Acute Lung Injury and ARDS: Research and Clinical Trials
    Critical Care Specialist
    University of California San Francisco

10:05 am-10:25 am
Coffee Break – Alhambra Ballroom & Terrace
Visit Exhibits/Posters

10:25 am-10:45 am
Covid Convalescent Plasma for the Treatment of COVID-19 Patients

  • Michael J. Joyner MD
    Caywood Professor of Anesthesiology
    Department of Anesthesiology & Perioperative Medicine
    Mayo Clinic

10:45 am-11:05 am
Real World Data-Lessons Learned from CCP for COVID-19 (Virtual)

  • Peter Marks MD, PhD
    Director of the Center for Biologics Evaluation and Research
    US FDA

11:05 am-11:15 am
Question & Answer Panel | Session 5

Session 6 | One Health Driving Translational Development for Novel Therapeutics

This session will explore the concept of One Health investigation in animals and how these studies can drive and advance translation of novel therapies to humans.

Moderator

  • Heather Pidcoke MD, PhD
    Chief Medical Research Officer, OVPR
    Joint Faculty, Dept. Clinical Sciences, CVMBS
    Colorado State University

  • Timothy Hackett DVM
    Alexander de Lahunta Chair, Department of Clinical Sciences
    Professor of Emergency and Critical Care Medicine
    College of Veterinary Medicine
    Cornell University

11:15 am-11:30 am
One Health Driving Translational Development: The University Perspective

  • Tracy Webb DVM, PhD
    Research Scientist
    Colorado State University

11:30 am-11:45 am
One Health Driving Translational Development: The FDA Perspective

  • Lynne Boxer DVM
    Veterinary Medical Officer FDA
    Office of new Animal Drug Evaluation

11:45 am-12:00 pm
What is this Veterinary Data doing in My BLA? HBOCs/Lyophilized Blood Products/Stem Cells

  • Anne S. Hale DVM
    Chief Development Officer
    Personalized Stem Cells

12:00 pm-12:15 pm
Initiatives in Veterinary Trauma: A Model for RDCR In Austere Environments

  • Kelly Hall
    DVM, MS, DACVECC
    Associate Professor, Critical Care Services
    Colorado State University
    Executive Director, ACVECC VetCOT

12:15 pm-12:25 pm
Question & Answer Panel | Session 6

12:25 pm-1:25 pm
Lunch – Valencia Lawn

1:25 pm-1:35 pm
CTTACC Transfusion Medicine Award Presentation

Session 7 | Regenerative Medicine and Stem Cells for Trauma and Critical Care

This session will focus on a number of regenerative and reparative approaches to mitigating outcomes in trauma and critical care medicine. CAR-T cell technology and advances will be discussed in the context of how they may be of potential use in injury and other diseases.

Moderator(s)

  • James Guest MD, PhD
    Professor of Neurological Surgery
    University of Miami, Miller School of Medicine
  • Michael Matthay MD
    Professor of Pulmonary Critical Care Medicine
    Research Lab Director, Acute Lung Injury and ARDS: Research and Clinical Trials
    Critical Care Specialist
    University of California, San Francisco

1:35 pm-1:55 pm
Enabling Technologies for Stem Cell Delivery to Wounds

  • Geoffrey Gurtner MD, FACS
    Chair, Department of Surgery
    Professor, Surgery
    Professor, Biomedical Engineering
    University of Arizona College of Medicine

1:55 pm-2:15 pm
Regenerating and Repairing Organ Damage Induced by Severe Injury with Novel Cryoprecipitate Products

  • Rosemary Kozar MD, FACS
    Professor, Surgery, Dept of Surgery
    Director of Translational Research, Shock Trauma Center
    Co-Director of STAR-ORC
    University of Maryland Baltimore
2:15 pm-2:35 pm

Extracellular Vesicles: Communicators and Carriers of Therapeutic Cargo in Trauma
  • Alpa Mahuvakar PhD
    Research Professor
    University California San Francisco
 
2:35 pm-2:55 pm

Bioprocessing and Ex Vivo Therapeutic Use of Mesenchymal Stromal Cells for Renal Repair

  • Biju Parekkadan PhD
    Associate Professor, Biomedical Engineering,
    Rutgers University

2:55 pm-3:15 pm
OMX, A Novel Oxygen Delivery Biotherapeutic for Treatment of Hemorrhagic Shock

  • Emin Maltepe, MD
    Professor Department of Pediatrics and Neonatology UCSF

3:15 pm-3:35 pm
Nanobody-Based CAR-T Cells and Potential Applications

  • Arun Wiita MD, PhD
    Associate Professor, Department of Laboratory Medicine, UCSF
    Assistant Director, UCSF Clinical Cytogenetics Laboratory
    Director, UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative Laboratory

3:35 pm-3:55 pm
The Development of Smarter CART-T Cells

  • Francesco Marincola MD
    Chief Scientific Officer
    Sonata Therapeutics, Inc.

3:55 pm-4:05 pm
Question & Answer Panel | Session 7

4:05 pm-4:20 pm
Coffee Break– Alhambra Ballroom & Terrace
Visit Exhibits/Posters

4:20 pm-4:40 pm
Antimicrobial Properties of Stem Cells in Wound Healing

  • Steve Dow DVM, PhD
    Professor of Immunology
    Director of the Center for Immune and Regenerative Medicine
    Colorado State University

4:40 pm-4:55 pm
Human Placental Stem Cell-Based Combination Therapies for Prevention of Abdominal Adhesions

  • Samuel Carmichael, MD
    Assistant Professor of Surgery
    Wake Forest School of Medicine – Baptist Medical Center
    North Carolina

4:55 pm-5:15 pm
Vascular Regeneration with Human Acellular Vessels

  • Luigi Pascarella, MD, FACS
    Professor of Surgery
    Vice Chair for Diversity, Equity, and Inclusion
    Director of Surgery Clerkship
    Division of Vascular Surgery
    Department of Surgery
    The University of North Carolina at Chapel Hill

5:15 pm-5:25 pm
Question & Answer Panel | Session 7

Session 8 | Product Development for Disaster Medicine – Threat X

This session with discuss countermeasures for a variety of mass disasters.
Moderator(s)

  • Mary Homer, PhD
    Chief United States Radiological and Nuclear Countermeasures,
    Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
    Biomedical Advanced Research and Development Authority (BARDA)

     

  • Mitchell Cohen MD, FACS
    Professor of Surgery and Vice Chair of Research
    University of Colorado

5:25 pm-5:40 pm
A Threat Agnostic Approach to Treating Injuries with Host Directed Therapeutics

  • Kimberly Hofmeyer, PhD
    Department of Health and Human Services
    BARDA

5:40 pm-5:55 pm
Animal Model Considerations for Development of Blood Products to Prevent, Mitigate, or Treat “Threat X”

  • Isabel Lauren Jackson, PhD
    Founding Principal
    True North BioPharma, LLC

     

  • Melanie Doyle-Eisele, PhD
    Senior Director Life Sciences/Laboratory Animal Sciences at Lovelace Biomedical

5:55 pm-6:10 pm
Development of Countermeasures to Address Threat X Using Human Organ Chips

  • David Chou MD, PhD
    Clinical Fellow, Ingber Lab
    Wyss Institute for Biologically Inspired Engineering at Harvard University

6:10 pm-6:25 pm
The Biology of Threat X: Coagulation, Inflammation, Immune and Endothelial Perturbations After Critical Injury and Illness. Implications for Generalized Countermeasures and Personalized Medicine

  • Mitchell Cohen, MD
    Professor of Surgery and Vice Chair of Research
    University of Colorado

6:25 pm- 6:35 pm
Question & Answer Panel | Session 8

6:35 pm-7:35 pm
Reception – Valencia Lawn

7:35 pm-10:00 pm
Dinner – Valencia Lawn
CTTACC Awards Presentation

Thursday, May 11 | Clinical Trial Design, Product Development and Sustaining Funding for Research

7:00 am-8:00 am
Breakfast – Alhambra Terrace

7:00 am-12:00 pm
Registration Desk Open – Alhambra Foyer
Badge and Materials Pick Up

8:00 am-8:05 am
Welcome & Introductions

  • Heather Pidcoke MD, PhD
    Chief Medical Research Officer, OVPR
    Joint Faculty, Dept. Clinical Sciences, CVMBS
    Colorado State University

Special Interest Talk

8:05am-8:25am
Platelets Made In Vitro: Opportunities and Challenges

  • Cédric Ghevaert MD, PhD, FRCP, FRCPath
    Professor of Transfusion Medicine
    University of Cambridge
    Consultant Haematologist
    NHS Blood and Transplant

Session 9 | Optimizing Clinical Trial Design to Support Advancement of Novel Therapies and Critical Care Medicine

Moderator(s)

  • Jason Sperry MD, MPH, FACS
    Section Chief, Trauma Surgery
    Professor of Surgery and Critical Care
    Director of Acute Care Surgery Fellowship
    University of Pittsburgh

  • Charles S. Cox Jr. MD, FACS
    The George and Cynthia Mitchell Distinguished Chair in Neurosciences
    Director, Children’s Program in Regenerative Medicine
    Professor, Department of Pediatric Surgery
    UTHealth Houston

8:25 am-8:45 am
Resuscitating (with) Thomas Bayes

  • Jan Jansen MBBS, PhD, FRCS
    Professor | Division of Trauma & Acute Care Surgery
    Director | Center for Injury Science
    Associate Vice Chair for Clinical Trials | Department of Surgery
    University of Alabama at Birmingham

8:45 am-9:05 am
Adaptive Platform Clinical Trial Design

  • Roger J. Lewis MD, PhD
    Senior Medical Scientist, Berry Consultants, LLC
    Investigator, The Lundquist Institute
    Professor of Medicine, David Geffen School of Medicine at UCLA

9:05 am-9:25 am
Sex Differences as Critical Considerations in Pre-Clinical and Clinical Development Pathways – What Took Us So Long?

  • Laura Ruse Brosch RN, PhD
    COL ANC USA (ret)
    Assistant Vice President for Research Initiatives and Compliance
    Uniformed Services University of the Health Sciences

9:25 am-9:45 am
Long-term Outcomes Research in Trauma and Critical Care Medicine

  • Joe Cuschieri, MD
    Professor of Surgery and Lab Medicine
    Interim Chief of Surgery
    Trauma Medical Director at Zuckerberg San Francisco General Hospital and Trauma Center
    University of California San Francisco

9:45 am-10:05 am
The Evidence on Hemostatic Resuscitation for Children with Life Threatening Bleeding

  • Phil Spinella, MD, FCCM
    USA
    Professor in the Departments of Surgery and Critical Care Medicine
    Co-Director of the Trauma and Transfusion Medicine Research Center
    Associate Medical Director of the Center for Military Medicine Research
    University of Pittsburgh

10:05 am-10:15 am
Question & Answer Panel | Session 9

10:15 am-10:30 am
Coffee Break – Alhambra Ballroom & Terrace
Exhibits closed and dismantled

Special Interest Talk

10:30 am-10:50 am
The Therapeutic Potential for Integrative Medicine in Acute and Chronic Illness

  • Virginia Von Schaefer MD
    Medical Director
    Integrative Oncology & Medicine Clinic – VVS MD, CA

10:50 am-11:00 am
Moderator Q&A – Shibani Pati, MD

Session 10 | Funding and Sustainability of Research Panel

This session will be focused on funding and sustainability of support for novel therapeutics in trauma and critical care. Points of discussion will include how to fund Phase 3 trials, how to advance translation to patients, and how to sustain research funding and support in this field through industry and federal agency partnerships.

Moderator(s)

  • Kenneth Bertram MD, PhD
    Co-Chair CTTACC
    COL MC USA (Ret)
    Clinical Product Development Officer
    Wake Forest University

     

  • Heather Pidcoke MD, PhD
    Chief Medical Research Officer, OVPR
    Joint Faculty, Dept. Clinical Sciences, CVMBS
    Colorado State University

11:00 am-11:15 am
Funding Through MRMC

  • Travis Polk, MD
    Director, DoD Combat Casualty Care Research Program
    CAPT USN

    Chair, Joint Program Committee-6
    Director, Combat Casualty Care Research Program (CCCRP)
    US Army Medical Research and Development Command (USAMRDC)
    Defense Health Agency
    Ft Detrick, MD
 

11:15 am-11:45 am
Panel Discussion

  • Travis Polk, MD
    Director, DoD Combat Casualty Care Research Program
    CAPT USN
    Chair, Joint Program Committee-6
    Director, Combat Casualty Care Research Program (CCCRP)
    US Army Medical Research and Development Command (USAMRDC)
    Defense Health Agency
    Ft Detrick, MD

     

  • Mary Homer, PhD
    Chief United States Radiological and Nuclear Countermeasures,
    Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
    Biomedical Advanced Research and Development Authority (BARDA)

  • Melinda Hamer MD, MPH, FACEP
    Deputy Director, Operations
    LTC USA
    Congressionally Directed Medical Research Programs
    Associate Professor of Military and Emergency Medicine at Uniformed Service University

  • Keith Hoots MD

Session 11 | Challenges of Product Development Talk Panel

This session will focus on the challenges of product development for novel cell therapies and blood products.

Moderator(s)

  • Becky Cap MBA
    SVP, Business Development, Advanced Therapies
    BioBridge Global
  • Mary Homer, PhD
    Chief United States Radiological and Nuclear Countermeasures,
    Division of Chemical, Biological, Radiological, and Nuclear Countermeasures
    Biomedical Advanced Research and Development Authority (BARDA)

11:45 am-12:05 pm
Challenges of Cell Therapy Product Development

  • Fabio Triolo D.d.R., M.Phil., PhD
    The Clare A. Glassell Distinguished Chair
    Director, Cellular Therapy Core
    Professor, Department of Pediatric Surgery
    UTHealth Houston

12:05 pm-12:25 pm
Challenges of Novel Blood Product Development

  • Lisa Buckley MPH
    Director of Clinical Trials and Regulatory Affairs, Velico Inc.
    OHSU Center for Regenerative Medicine

12:25 pm-12:45 pm
Challenges with Manufacturing Mesenchymal Stromal Cells for Clinical Trials

  • David Stroncek MD
    Director, Center for Cellular Engineering, National Institutes of Health

12:45 pm- 1:00 pm
Overcoming Challenges in the Cellular Therapy Laboratory

  • Patrick Hanley PhD
    Chief & Director, Cellular Therapy Program
    Associate Professor of Pediatrics
    Children’s National Hospital
    The George Washington University

1:00 pm- 1:20 pm
Concluding Remarks

  • Shibani Pati MD, PhD
    CTTACC Conference Chair
    Professor of Laboratory Medicine and Surgery, UCSF
    Scientific Director of Cellular Therapies

  • Heather Pidcoke MD, PhD
    Chief Medical Research Officer, OVPR
    Joint Faculty, Dept. Clinical Sciences, CVMBS
    Colorado State University

1:20 pm-2:00 pm
Lunch – Alhambra Terrace

Conference Adjourns

Presented by the University of California San Francisco Department of Laboratory Medicine

Presented by the Office of the Vice President of Research, the College of Veterinary Medicine and Biomedical Sciences, and the Infectious Disease Research Center.

SIGNUP FOR MORE INFORMATION

Questions? Email us at info@cttacc.org or call 303-238-0685